Cellino is the first cell and tissue foundry with single-cell precision for the regenerative medicine industry. By combining laser optics, machine learning, and stem cell biology, Cellino's platform technology provides an automated end-to-end solution for developing and manufacturing highly-functional sheets of iPSC-derived cells.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
automated platform technology
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):